Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024

HACKENSACK, NJ / ACCESSWIRE / December 5, 2024 / Champions Oncology, Inc. (NASDAQ: CSBR), a global provider of preclinical and clinical research services that delivers end-to-end oncology solutions, will report financial and operating results for the second quarter ended October 31, 2024, on Wednesday December. December 11, 2024, after close of trading. The company will host a conference call to discuss the results that day at 4:30 p.m. EST (1:30 p.m. PST). To join the call, dial 888-506-0062 (domestic) or 973-528-0011 (international) and enter passcode 710610. A replay of the call will be available by dialing 877-481- 4010 (national) or 919-882-2331 (International) and entering the code: 51750, or by accessing the investors section of the company’s website within 72 hours.

About Champions Oncology, Inc.

Champions Oncology is a global preclinical and clinical research services provider that delivers end-to-end oncology R&D solutions to biopharmaceutical organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) models and primary hematological malignancies, Champions delivers innovative data of the highest quality via proprietary in vivo and ex vivo platforms . With its broad portfolio of cutting-edge bioanalytical platforms, groundbreaking data and analytics platform, and scientific excellence, Champions enables the advancement of preclinical and clinical oncology drug discovery and development programs worldwide. For more information, please visit www.ChampionsOncology.com.

SOURCE: Champions Oncology, Inc.

View the original press release at accesswire.com